Skip to main content

Table 1 Demographic characteristics of study subjects in ADNI

From: Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration

Characteristics

NC (N = 339)

MCI (N = 639)

AD (N = 205)

Age (mean years ± SD)

75.15 ± 5.35

73.44 ± 7.52

75.53 ± 7.81

Gender (n (%))

  

 Male

177 (52.21)

389 (60.88)

117 (57.07)

 Female

162 (47.79)

250 (39.12)

88 (42.93)

Education (mean years ± SD)

16.30 ± 2.68

15.89 ± 2.84

15.03 ± 2.96

APOE status (n (%))

APOE ε2/ε2,ε2/ε3,ε3/ε3

247 (72.86)

325 (50.86)

66 (32.20)

APOE ε2/ε4,ε3/ε4

83 (24.48)

250 (39.12)

101 (49.27)

APOE ε4/ε4

9 (2.65)

64 (10.02)

38 (18.54)

MMSE (means ± SD)

29.07 ± 1.12

27.60 ± 1.78

23.29 ± 2.03

  1. Abbreviations: AD Alzheimer’s disease, ADNI Alzheimer’s Disease Neuroimaging Initiative, MCI mild cognitive impairment, MMSE Mini-Mental State Exam scores, N number, NC normal cognition, SD standard deviation